Helmsley Cellular Research Hub

Introduction of operations for the Helmsley Cellular Research Hub

Call for Investigators with Research Interests Related to Stem Cells and Type 1 Diabetes


The purpose of this announcement is to draw attention to a novel and important new resource for diabetes researchers: the formation of the Helmsley Cellular Research Hub.

The Helmsley Cellular Research Hub was established as part of a type 1 diabetes coalition comprised of the Naomi Berrie Diabetes Center at Columbia University, the New York Stem Cell Foundation and the University of Florida Diabetes Institute, with funding support from The Leona M. and Harry B. Helmsley Charitable Trust. The goal of the Helmsley Cellular Research Hub is to promote a greater understanding of type 1 diabetes and accelerate new potential therapies to treat the disease.

Thanks to the support of the Helmsley Charitable Trust, a number of somatic and pluripotent cell lines obtained from well-phenotyped type 1 diabetes patients and suitable controls/patients with other forms of diabetes are now available to qualified research scientists.

For more information, please see our website (www.cellhub.org). There, you will have the ability to review the available samples catalog and should you have questions, please contact us. We welcome comments and suggestions regarding this resource.